Drug Approval | August 16, 2021
Researchers develop remote ultrasound imaging using robotic technology
The project is a collaboration between IIT Delhi and AIIMS
The project is a collaboration between IIT Delhi and AIIMS
The approval is based on a multi-centre, single-arm, open-label pivotal clinical trial
Ultreon 1.0 Software, the first-of-its-kind imaging software, merges optical coherence tomography with the power of automation using AI -
The company had announced the expected date of completion of sale and disposal of the said undertaking is 90 days from the date of signing the Definitive Agreements.
The company plans to aggressively invest in longer gestation period projects like innovation, biosimilars, vaccines, etc.
The deal is to sell one of the two business undertakings of ZAHL for a lump sum consideration of Rs. 2921 crores on a cash free and debt free basis,
Both the vaccines have been extensively tested by IVRI for safety and potency and have been found to provide 100% protection
If cleared, MAVIRET would become one of the few therapies in the European Union approved to treat both acute and chronic hepatitis C infections
If approved, TEV-‘749 would mark a shift toward long-acting care aimed at improving treatment adherence in real-world settings
The decision marks a key step in the centralized EU review process
Subscribe To Our Newsletter & Stay Updated
